Beta Bionics, Inc. Common Stock (BBNX) earnings · rev $100.3M
These earnings events as JSON? API free 100/dayBeta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
This BBNX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
When the next BBNX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 53.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BBNX research stays on the stock page; the tape stays on the quote page.
BBNX earnings FAQ
What are BBNX's latest revenue and net income?
Latest cached Beta Bionics, Inc. Common Stock (BBNX) revenue for Dec 31, 2025 was $100.3M. Net income was -$73.2M. Statements: https://lician.com/financials/bbnx
What is BBNX's latest diluted EPS?
Latest cached Beta Bionics, Inc. Common Stock (BBNX) diluted EPS for Dec 31, 2025 was -$1.81.
What period does the latest BBNX earnings print cover?
The latest cached Beta Bionics, Inc. Common Stock (BBNX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BBNX revenue change from the prior cached period?
Cached Beta Bionics, Inc. Common Stock (BBNX) revenue was up 53.9% from $65.1M (Dec 31, 2024) to $100.3M (Dec 31, 2025). Statements: https://lician.com/financials/bbnx
Where are BBNX earnings listed?
Cached earnings facts for Beta Bionics, Inc. Common Stock (BBNX) are listed at https://lician.com/earnings/bbnx. Statements: https://lician.com/financials/bbnx
Not investment advice.